Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol

By sjmartinez • November 29, 2024

Newell-Price J, Fleseriu M, Pivonello R, Feelders RA, Gadelha MR, Lacroix A, Witek P, Heaney AP, Piacentini A, Pedroncelli AM, Biller BMK. Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol. J Endocr Soc. 2024 Nov 12;9(1):bvae201. doi: 10.1210/jendso/bvae201. PMID: 39610378; PMCID: PMC11604051.

Tags: cortisol normalization, Cushing disease, Endocrinology, hypercortisolism, long-term treatment, osilodrostat, Publications

ERalpha activates NAMPT/IL-33 signaling to enhance beige thermogenesis and metabolic fitness

Hu R, Park J, Qian Y, Xiong S, Elsabbagh AH, Chhikara A, Fan H, Shi Z, Liu L, Li Y, Song Z, Mahmoud AM, Chen[...]

Testosterone deficiency synergistically exacerbates fructose-induced hepatic steatosis through gut microbiota and pyruvate in mice

Takahashi H, Harada N, Hayamizu Y, Dungubat E, Nakazawa M, Kitakaze T, Sugimoto K, Inui H, Yoshihara E, Takahashi Y, Yamaji R. Testosterone deficiency synergistically[...]

Adrenal Mass and Extensive Brown Fat Activation in a Young Female With Urinary Frequency and Hypertension

Shahinyan M, Yu R. Adrenal Mass and Extensive Brown Fat Activation in a Young Female With Urinary Frequency and Hypertension. AACE Endocrinol Diabetes. 2025 Jul[...]